Most of us think of Verizon (NYSE:VZ) in terms of its telecom business, but this global giant also has a large health care branch, including a chief medical officer.
Verizon had a large presence at the recent mHealth Summit near Washington, D.C. -- a large show that sits squarely at the intersection of mobile technology and health care. The Fool's Max Macaluso and Rex Moore attended the fifth-annual summit to learn where mobile health is today and what lies ahead. While there, they chatted with Nancy Green, managing principal of Verizon's health care practice, to learn more about the company's multibillion dollar health segment.
In this video, Nancy talks about some of the products Verizon provides.
A full transcript follows the video.
A stock with tremendous potential for 2014...
There’s a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it’s one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
Max Macaluso: Can you run down a few of your top products for us?
Nancy Green: We're at the mHealth show, so let me start there.
At the mHealth show we're highlighting our Converged Health Management product, which is that remote patient monitoring, Class II device -- although it's cloud-based, so it's a little different -- which works with weight scales and blood pressure cuffs and pulse oximeters, that kind of stuff; so that's in mobile health.
We'll be coming out with some other products that add video to it, so we have video products, Universal Identity security work. The Universal Identity is a product that Verizon has. It's a couple years old. We have applied it to health care and fixed a couple problems in health care utilizing the authentication of you and I -- authentication of the consumer, or authenticating a person; a clinician, in this instance.
What we've been able to do, to work with electronic health records in pharmacies, is to do electronic prescriptions in a mobile environment. That's for Schedule II drugs, which are narcotics, which is very difficult to do.
We worked through all that process so that a physician can actually do it, prescribing a Schedule II drug, over his mobile or his device. It's very innovative, because it helps them be able to be on the move -- back to my point of mobile health.
Max Macaluso, Ph.D. has no position in any stocks mentioned. Rex Moore has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.